Annual Accounts Payable
$2.38 M
+$1.99 M+519.20%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual accounts payable is $2.38 million, with the most recent change of +$1.99 million (+519.20%) on December 31, 2023.
- During the last 3 years, XLO annual accounts payable has risen by +$1.70 million (+249.49%).
- XLO annual accounts payable is now at all-time high.
Performance
XLO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$972.00 K
-$292.00 K-23.10%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly accounts payable is $972.00 thousand, with the most recent change of -$292.00 thousand (-23.10%) on September 30, 2024.
- Over the past year, XLO quarterly accounts payable has dropped by -$78.00 thousand (-7.43%).
- XLO quarterly accounts payable is now -88.44% below its all-time high of $8.41 million, reached on June 30, 2021.
Performance
XLO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XLO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +519.2% | -7.4% |
| 3 y3 years | +249.5% | -7.4% |
| 5 y5 years | +1730.9% | -7.4% |
XLO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +585.3% | -69.1% | +30.3% |
| 5 y | 5-year | at high | +753.0% | -88.4% | +30.3% |
| alltime | all time | at high | +9368.1% | -88.4% | +30.3% |
Xilio Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $972.00 K(-23.1%) |
| Jun 2024 | - | $1.26 M(+69.4%) |
| Mar 2024 | - | $746.00 K(-29.0%) |
| Dec 2023 | $2.38 M(+519.2%) | $1.05 M(-29.3%) |
| Sep 2023 | - | $1.49 M(+57.2%) |
| Jun 2023 | - | $945.00 K(-53.1%) |
| Mar 2023 | - | $2.01 M(-35.6%) |
| Dec 2022 | $383.80 K | $3.13 M(+72.7%) |
| Sep 2022 | - | $1.81 M(+28.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.41 M(-39.3%) |
| Mar 2022 | - | $2.32 M(-26.1%) |
| Dec 2021 | $346.80 K(-49.0%) | $3.14 M(-17.7%) |
| Sep 2021 | - | $3.82 M(-54.5%) |
| Jun 2021 | - | $8.41 M(+54.5%) |
| Dec 2020 | $680.00 K(+144.1%) | $5.44 M |
| Dec 2019 | $278.60 K(+114.6%) | - |
| Dec 2018 | $129.80 K(+1.1%) | - |
| Dec 2017 | $128.40 K(+411.6%) | - |
| Dec 2016 | $25.10 K | - |
FAQ
- What is Xilio Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Xilio Therapeutics?
- What is Xilio Therapeutics annual accounts payable year-on-year change?
- What is Xilio Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly accounts payable year-on-year change?
What is Xilio Therapeutics annual accounts payable?
The current annual accounts payable of XLO is $2.38 M
What is the all time high annual accounts payable for Xilio Therapeutics?
Xilio Therapeutics all-time high annual accounts payable is $2.38 M
What is Xilio Therapeutics annual accounts payable year-on-year change?
Over the past year, XLO annual accounts payable has changed by +$1.99 M (+519.20%)
What is Xilio Therapeutics quarterly accounts payable?
The current quarterly accounts payable of XLO is $972.00 K
What is the all time high quarterly accounts payable for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly accounts payable is $8.41 M
What is Xilio Therapeutics quarterly accounts payable year-on-year change?
Over the past year, XLO quarterly accounts payable has changed by -$78.00 K (-7.43%)